GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | +33.3% | 182 | +23.8% | 0.00% | +100.0% |
| Q1 2022 | $6,000 | +50.0% | 147 | +48.5% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | 0.0% | 99 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | 0.0% | 99 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | -20.0% | 99 | -35.7% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -92.2% | 154 | -91.2% | 0.00% | -94.4% |
| Q4 2020 | $64,000 | +1.6% | 1,747 | +4.5% | 0.02% | -18.2% |
| Q3 2020 | $63,000 | -25.0% | 1,672 | -18.5% | 0.02% | -24.1% |
| Q2 2020 | $84,000 | +425.0% | 2,051 | +372.6% | 0.03% | +314.3% |
| Q1 2020 | $16,000 | -20.0% | 434 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $20,000 | +11.1% | 434 | +0.9% | 0.01% | 0.0% |
| Q3 2019 | $18,000 | +28.6% | 430 | +29.9% | 0.01% | 0.0% |
| Q2 2016 | $14,000 | – | 331 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |